Meet the HAL Allergy Board of Directors
The Executive Board of Directors:
Harry P. Flore (PhD)
Chief Executive Officer (CEO)
20 years experience in the pharmaceutical industry in the USA and EU with broad knowledge of quality systems (GMP, ISO) and proven leadership skills in both scientific and production settings.
Karl G. Prusky
Chief Commercial Officer (CCO)
40 years experience with multinationals in the pharmaceutical industry managed, developed and reorganized businesses in Africa, Central & South America, Europe and the Middle East.
Guntram Nöth (PhD)
Chief Financial Officer (CFO)
15 years experience in different industries in Europe, Northern America, and Asia with proven leadership skills in finance and performance improvement.
The Directors:
| Carola Trommels (LLM) Corporate Strategy Master degree in international law with over 20 years experience in the vaccine industry. Experience with international legal and strategic corporate development. |
| Stef Koppelman (PhD) Research & Development PhD in Biochemistry with over 15 years experience in the Pharmaceutical industry aligning R&D with sales and business development. In 2008 was appointed Professor at the University of Nebraska. |
